Great potential but BAD leadership - Account Executive Baxter Employee Review

2.0
24 Mar 2014
Recommend
CEO approval
Business outlook

Pros

In the Renal devision, the products are life sustaining and patient user friendly. Baxter invests in R&D and will introduce improved devices for home dialysis patients in the near future. Baxter will continue to be seen as an expert in the home dialysis therapies because of its 30 plus years in the specialized home dialysis arena. Field sales salaries are in the high end of the spectrum. Perks are comparable to the industry standards.

Cons

Disconnect between corporate leadership and field sales employes. Bad trickle down communication and distribution of important information. Management is "old school" and refuses to change. Most managers are near the end of their careers and are just waiting to retire and truly don't have the best interest of the company's future in mind. Management has been around for years and very little has been expected of them, do to the small market share of the home dialysis therapies and very small portion of the overall business at Baxter.This has changed in the last couple of years and management can't keep up with what is happening in technology, FDA regulations and compliance standards. Very sad to see management disconnected and more worried about themselves and not the customers they serve.

Explore other reviews about Baxter

5.0
15 Apr 2026
Recommend
CEO approval
Business outlook

Pros

Great place to work. Overall truly enjoyed my time at Baxter.

Cons

None than come to mind

avatar
Baxter Response
1mo
Thank you for your kind words and for the impact you made during your time at Baxter. It means a great deal to hear that your experience was so positive, and we are grateful for the contributions you made as part of our team!
1.0
22 Jun 2026
Recommend
CEO approval
Business outlook

Pros

Sometimes pay, but not worth potentially losing your job

Cons

Layoffs every few months. Too many middle management that don't have any technical skills. Will be sold off to equity firms in the next 5 to 10 years

See reviews by: Helpful|Rating|Date|All